Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 061529/0093 | |
| Pages: | 10 |
| | Recorded: | 10/25/2022 | | |
Attorney Dkt #: | 02020.115US6 |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
1
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17940902
|
Filing Dt:
|
09/08/2022
|
Publication #:
|
|
Pub Dt:
|
05/11/2023
| | | | |
Title:
|
N4-phenyl-quinazoline-4 -amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
|
|
Assignee
|
|
|
3200 WALNUT STREET |
BOULDER, COLORADO 80301 |
|
Correspondence name and address
|
|
VIKSNINS HARRIS PADYS MALEN LLP
|
|
7851 METRO PARKWAY
|
|
SUITE 325
|
|
BLOOMINGTON, MN 55425
|
Search Results as of:
04/29/2024 08:18 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|